CClinicalTrials.gg
CompletedNCT01042171Updated Jul 18, 2012

Evaluation of Image Quality Over Time After Injection of the fluorescein Sodium for Confocal Laser Endomicroscopy

An observational study in Change of Image Quality of CLE, sponsored by Shandong University. Completed at 1 site in China. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2012-07-18.

Sponsored by Shandong University · Observational

Study type
Observational
Time perspective
Prospective
Enrollment
20
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Confocal laser endomicroscopy (CLE) is a newly developed endoscopic technique. The most commonly used fluorescent substance is Fluorescein sodium.The plasma half-life of fluorescein is 11 minutes. A recent test estimated that fluorescein-based CLSM(confocal laser scanning microscopy) of the upper-GI tract of pigs delivers the best contrast and image quality within the first 8 minutes after injection of fluorescein .However, despite its increasing use in clinical examination,there are no data on contrast dynamics and image quality over time after injection of the fluorescein sodium in the inspection of gastrointestinal tract of human being.

02

Conditions studied

  • Change of Image Quality of CLE
03

In context

Lead sponsor

Shandong University is the lead sponsor of 284 studies on the registry; 59 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

patients without any disease of heart,liver or kidney;patients without serious gastritis and other serious stomach lesions.

Inclusion criteria

  • These subjects will include male or female aged between 18 and 60 years with indications for upper-endoscopy ,but without serious gastritis and other serious stomach lesions

Exclusion criteria

Exclusion Criteria:

  • Complications such as gastric and/or duodenal peptic ulcer, stenosis
  • Esophageal, gastric or duodenal cancer or other malignancy
  • History of stomach surgery
  • A history of bronchial asthma, or known allergy to fluorescein.
  • Pregnant or breast-feeding (for females)
  • Below 18 or above 60 years of age
  • Severe comorbidities ( e.g. such as renal failure, congestive cardiac failure, liver cirrhosis).
05

Study design

Time perspective
Prospective
Enrollment
20 participants (actual)
06

What researchers measure

Primary outcomes

  1. The ideal time period for the best CLE imaging when using fluorescein sodium is about 10 minutes

    Time frame: Within the 30 minutes after injection of fluorescein

07

Study locations

1 site
  • Department of Gastroenterology, Qilu Hospital, Shandong University
    Jinan, Shandong 250012, China
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 18, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01042171
Lead sponsor
Shandong University
Responsible party
Yanqing Li (Chief of the Department of Gastroenterology, Qilu Hospital, Shandong University) — Principal investigator
First posted
Jan 5, 2010
Start date
Dec 2009
Primary completion
Jun 2010
Completion
Jun 2010
Last update
Jul 18, 2012

Study contacts

Yanqing Li, PhD. MD.
study director · Department of Gastroenterology, Qilu Hospital

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion